Navigation Links
Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards
Date:6/20/2011

NEW YORK, June 20, 2011 /PRNewswire/ -- Merisel, Inc. (OTC: MSEL) operating under its principal brand Coloredge New York - Los Angeles, a leading provider of visual communications and brand imaging solutions, was awarded "Business Turnaround of the Year" last night at the 9th Annual American Business Awards Ceremony, in recognition of its agility to adapt, grow, and maintain its commitment to delivering solid results, despite prevailing economic turbulence.

The American Business Awards, part of The Stevie Awards program, honors the achievements and contributions of US-based businesses and their employees.  Awards were presented in over 40 categories and more than 2,800 entries were received from organizations of all sizes in virtually every industry.  Merisel itself was a finalist for ten awards in seven categories, including "Best Overall Company of the Year," "Business Innovation of the Year," and "Turnaround Executive of the Year."

The distinction of "Business Turnaround of the Year" is awarded to the company that showed significant operational and financial improvement in 2010 over 2009. The winning nomination stated:

[Merisel] ended 2009 with a 26% decline in net sales vs. 2008 and an operating loss of $9.3 million (adjusted to exclude one-time non-cash expenses).  We finished 2010 with 15.9% year-on-year revenue growth and strong operating income of $1.5 million, resulting in a turnaround of $10.8 million.  Undoubtedly, [Merisel] achieved these results through persistent adherence to our three core tenets:  Consistently creating superior value for our customers, focusing our operations on efficiency, and instilling a culture defined by high-performance and excellence.

Upon accepting the award at last night's ceremony, Donald R. Uzzi, Chairman & CEO, stated, "We are honored to receive this prestigious recognition by The Stevie Awards for our diligent per
'/>"/>

SOURCE Merisel, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
2. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
3. Elanco Announces Acquisition of Posilac(R) Dairy Business
4. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
5. Chiltern Early Phase: Fully Integrated and Business Ready
6. Insulet Appoints Bill Arthur as Vice President of Business Development
7. Therapure Biopharma Inc. opens for business with first client contracts
8. Ohio Recognized as National Leader for Business Development and Job Creation
9. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
10. Cyberonics Provides Update on Business Operations Following Hurricane Ike
11. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , 27. März 2015  Peter ... in Biomedical Science für seine bahnbrechende Arbeit ... zwischen Zellkompartimenten transportiert werden, sowie für die ... zur Reaktion auf Stress nutzen, der mit ... Walter ist Professor für Biochemie an der ...
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... March 27, 2015 Working in collaboration ... in London , Richmond Pharmacology is the ... Phase 3 study for an investigational RNAi therapeutic being developed ... affecting the nerves and heart. Read press ... Based at St Georges University of ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
Breaking Biology Technology:Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6
... smaller and more complex every year. It turns out that ... to small devices, such as cell phones, hitting the floor. ... when dropped? , A team of Clemson University researchers, led ... to make beds of tiny, shock-absorbing carbon springs which possibly ...
... N.J., Aug. 13 At the upcoming Medical,Grade ... Team,Leader, will present "Silicone Elastomer Gels: New Soft ... in Philadelphia, September 16-17., According to Dr. ... that provide differentiated performance features for wound care,scar ...
... MS, - Milestone triggers $10 million payment ... Aug. 13 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX:,MS), ... sclerosis (MS), today,announced that the independent Drug Safety ... the scheduled interim analysis of efficacy,and safety and ...
Cached Biology Technology:Clemson scientists put a (nano) spring in their step 2Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference 2BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 2BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 3BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 4
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
(Date:3/10/2015)... March 10, 2015 Transforming How ... "Personalized Medicine in Human Space Flight" by ... J. Goodwin , Ph.D. was recently featured by Springer ... two years. Specifically, "Personalized Medicine in Human ... papers published in 2013 and 2014 from Springer in ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... WAYNE, Pa., Dec. 14 MODA Technology Partners, a ... and product testing for the Pharmaceutical industry, today announced ... generation mobile data acquisition platform. The latest release enables ... manufacturing processes. , MODA 3.0 includes the following ...
... team led by Yale University researchers has used nanosensors ... first time. Their findings, which appear December 13 in ... could dramatically simplify the way physicians test for biomarkers ... teamled by Mark Reed, Yale,s Harold Hodgkinson Professor of ...
... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ...
Cached Biology News:MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Horizontal string trimmer reduces labor costs, increases peach size 2
...
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
Reactivity: Human...
Biology Products: